← Back to Search

Device

Intra-Cardiac Echocardiography (ICE) for Left Atrial Appendage Occlusion

N/A
Waitlist Available
Led By Mohamad Adnan Alkhouli, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 45 days post procedure
Awards & highlights

Study Summary

This trial looks at whether a device to close off the left atrial appendage is safe and feasible when guided by an echocardiography under moderate sedation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~45 days post procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 45 days post procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Major complications
Successful implantation of WATCHMAN FLX device

Trial Design

1Treatment groups
Experimental Treatment
Group I: left atrial appendage (LAA) occlusion with the WATCHMAN FLX device using (ICE)Experimental Treatment1 Intervention
100 patients undergoing LAA closure with the WATCHMAN FLX utilizing an intra-procedural ICE probe under moderate sedation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
intra-procedural intracardiac echocardiography (ICE) probe
2022
N/A
~110

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,683 Total Patients Enrolled
Mohamad Adnan Alkhouli, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
101 Total Patients Enrolled

Media Library

Intra-procedural Intracardiac Echocardiography (ICE) Probe (Device) Clinical Trial Eligibility Overview. Trial Name: NCT05136417 — N/A
Left Atrial Appendage Occlusion Research Study Groups: left atrial appendage (LAA) occlusion with the WATCHMAN FLX device using (ICE)
Left Atrial Appendage Occlusion Clinical Trial 2023: Intra-procedural Intracardiac Echocardiography (ICE) Probe Highlights & Side Effects. Trial Name: NCT05136417 — N/A
Intra-procedural Intracardiac Echocardiography (ICE) Probe (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05136417 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment open to new participants at the moment?

"This trial, which was initially advertised on April 1st 2022, is not taking new enrollees at this moment. The last update to the information posted on clinicaltrials.gov occurred in November 3rd of the same year. Fortunately for prospective patients, there are currently 4 other studies actively recruiting participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Study of Intra-Cardiac Echocardiography in Guiding Left Atrial Appendage Occlusion With the Watchman Device
Mohamad Adnan Alkhouli 2022. "Study of Intra-Cardiac Echocardiography in Guiding Left Atrial Appendage Occlusion With the Watchman Device". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05136417.
~31 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top